Contents: 1.
Introduction to Pharmacogenomics:
Promises, Opportunities, and Limitations 2.
The Human Genome 3.
Turning SNPs into Useful Markers of Drug
Response 4.
Association Studies in Pharmacogenomics 5.
Genomics Applications That Facilitate
the Understanding of Drug Action and Toxicity 6.
The Role of Pharmacogenomics in Drug
Discovery and Therapeutics 7.
Pharmacogenomics and Drug Design 8.
The Pharmacogenomics of Human
P-Glycoprotein 9.
Pharmacogenomics of Drug Transporters 10.
Pharmacogenomics of Asthma Treatment 11.
Endothelial Cells Are Targets for
Hydroxy Urea: Relevance to the Current Therapeutic Strategy in Sickle Cell
Disease 12.
Pharmacogenomics and Complex
Cardiovascular Disease – Clinical Studies in Candidate Genes 13.
Pharmacogenomics of Lipid-Lowering
Agents 14.
Pharmacogenomics of Chemotherapeutic
Agents in Cancer Treatment 15.
Pharmacogenomics of the Blood–Brain
Barrier 16.
Pharmacogenomics and the Treatment of
Neurological Disease 17.
Pharmacogenomics of Neurodegenerative
Diseases: Examples and Perspectives 18.
Psychiatric Pharmacogenetics: Prediction
of Treatment Outcomes in Schizophrenia 19.
Pharmacogenomics of Major Depression and
Antidepressant Treatment 20.
Pharmacogenomics of Bipolar Disorder 21.
Pharmacogenomics of Alcoholism 22.
Pharmacogenomics of Tobacco Addiction 23.
Pharmacogenomics of Opioid Systems 24.
Ethnicity and Pharmacogenomics 25.
Pharmacogenomics: Ensuring Equity
Regarding Drugs Based on Genetic Difference 26.
Translation of Vascular Proteomics into
Individualized Therapeutics 27. Glossary
of Key Terms in Molecular Genetics and Pharmacogenomics |
